BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN)

CAPS Rating: 3 out of 5

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

Recs

0
Player Avatar iamluckyfool (< 20) Submitted: 9/12/2008 8:05:08 PM : Underperform Start Price: $27.11 BMRN Score: -30.63

684.75 P/E is absurd.

Report this Post Reply

Featured Broker Partners


Advertisement